Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

AMENDED FROM SOURCE – Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement

by admin April 17, 2025
April 17, 2025
AMENDED FROM SOURCE – Blue Sky Uranium Increases and Closes 2nd and Final Tranche of the Oversubscribed Non-Brokered Private Placement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

TSX Venture Exchange: BSK
Frankfurt Stock Exchange: MAL2

Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (‘Blue Sky’ or the ‘Company’) is pleased to announce that due to continued strong demand, the Company has increased the non-brokered private placement offering (the ‘ Offering ‘) to up to $1,649,800 in aggregate gross proceeds. All other terms of the Offering will remain the same as originally announced in the Company’s News Release dated March 27, 2025 .

The Company further announces that it has closed the second and final tranche of the non-brokered private placement through the issuance of 8,660,000 units at a subscription price of $0.05 per Unit for aggregate gross proceeds to the Company of $433,000 . In total, the Company issued 32,996,000 Units for total gross proceeds of $1,649,800 .

Each Unit consists of one common share and one warrant (a ‘ Warrant ‘). Each Warrant will entitle the holder thereof to purchase one additional common share in the capital of the Company at $0.07 per share for four years from the date of issue, expiring on April 16, 2029 for this tranche.

Finder’s fees of $3,500 are payable in cash on a portion of the private placement to parties at arm’s length to the Company. In addition, 70,000 non-transferable finder’s warrants are issuable (the ‘ Finder’s Warrants ‘).  Each Finder’s Warrant entitles a finder to purchase one common share at a price of $0.05 per share for four years from the date of issue, expiring on April 16, 2029 for this tranche. In total, cash finders’ fees of $28,560 were paid and 571,200 Finders’ Warrants were issued for the Offering.

No insiders participated in this tranche.

This Offering is subject to regulatory approval and all securities to be issued pursuant to the Offering in this final tranche are subject to a four-month hold period under applicable Canadian securities laws expiring on August 16, 2025 . The proceeds of the Offering will be used for general working capital.

About Blue Sky Uranium Corp.

Blue Sky Uranium Corp. is a leader in uranium discovery in Argentina . The Company’s objective is to deliver exceptional returns to shareholders by rapidly advancing a portfolio of surficial uranium deposits into low-cost producers, while respecting the environment, the communities, and the cultures in all the areas in which we work. Blue Sky has the exclusive right to properties in two provinces in Argentina . The Company’s flagship Amarillo Grande Project was an in-house discovery of a new district that has the potential to be both a leading domestic supplier of uranium to the growing Argentine market and a new international market supplier. The Company is a member of the Grosso Group, a resource management group that has pioneered exploration in Argentina since 1993.

ON BEHALF OF THE BOARD

‘Nikolaos Cacos’

______________________________________

Nikolaos Cacos , President, CEO and Director

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, nor will they be registered under the United States Securities Act of 1933, as amended, or state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. federal and state registration or an applicable exemption from the U.S. registration requirements. This release does not constitute an offer for sale of securities in the United States.

SOURCE Blue Sky Uranium Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2025/16/c0748.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

previous post
Top 5 Junior Copper Stocks on the TSXV in 2025
next post
Blue Lagoon Announces Final Tranche Of Private Placement

Related Posts

Cygnus Starts Trading on OTCQB Market

February 15, 2025

Halcones Precious Metals Announces Surface Outcrop Chip Channel...

February 8, 2025

Nickel Price Update: Q1 2025 in Review

April 23, 2025

Maverick Metals Secures US$19 Million to Fast Track...

April 9, 2025

Trump’s Auto Tariffs Ignite Global Trade Tensions and...

March 28, 2025

Greenvale $1.8m placement to fast-track uranium exploration

March 24, 2025

Editor’s Picks: Gold Hits New High, Silver Squeeze...

March 29, 2025

Cizzle Brands Corporation Schedules Second Fiscal Quarter 2025...

March 14, 2025

Visible Gold Above High Grade Cu-Au Porphyry –...

March 6, 2025

Top 5 Canadian Mining Stocks This Week: Lion...

May 3, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved